Diagnostics News and analysis on diagnostic technologies and applications. In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health A federal judge denied four motions by Guardant but granted four others by the company. Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine The companies aim to identify therapeutic targets for Niemann-Pick disease type C, a rare genetic lysosomal storage disorder. Protein-Based Liquid Biopsy Panel Assesses Tumor Microenvironment, Shows Prognostic Potential Premium A panel of 13 circulating proteins related to the tumor microenvironment may provide prognostic clues to prostate cancer progression. Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Project Beacon COVID-19 was started by F-Prime Capital, GV, and the Broad Institute to help implement COVID-19 testing in Massachusetts and its environs. Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay The diagnostics and research services firm will help Mainz recruit research partners for a study assessing new biomarker additions to its CRC early detection test. Jan 12, 2022 JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More Jan 11, 2022 Biofidelity Prepares to Launch Lung Cancer Mutation Detection Assay Premium Jan 11, 2022 FDA Grants Emergency Use Authorization for Premier Medical COVID-19 Test Jan 11, 2022 GeninCode Files FDA Pre-Submission for Cardiovascular Disease Risk Test Jan 11, 2022 JPM Healthcare Conference Day 1: Seer, Twist, 10x, Guardant, Natera, Bruker, Adaptive, Qiagen, Sema4 Jan 11, 2022 Freenome Nets $290M Investment From Roche Jan 11, 2022 SQI to Acquire Precision Biomonitoring SARS-CoV-2 Testing Business, Technology Jan 11, 2022 Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results Jan 11, 2022 Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference Jan 11, 2022 NeoGenomics Blood-Based Minimal Residual Disease Test Receives CE Mark Jan 10, 2022 Caris Life Sciences, HotSpot Therapeutics Partner to Develop Precision Medicines, CDx Tests Jan 10, 2022 Exact Sciences Projects up to $475M in Q4 Revenues, Acquires Testing Lab, Inks Licensing Deal Jan 10, 2022 Grail Partners With Premier's PINC AI to Improve Patient Access to Blood-Based Multi-Cancer Test Jan 10, 2022 CareDx, Castle Bio, Lucira Health, Others Announce Preliminary Q4, FY21 Earnings Results Jan 10, 2022 Hologic Preliminary Fiscal Q1 Revenues Drop 9 Percent Jan 10, 2022 Exagen, QMUL to Develop Molecular Signatures for Rheumatoid Arthritis Therapy Selection Jan 7, 2022 Epic Sciences Prepares to Launch Multi-Analyte Metastatic Breast Cancer Liquid Biopsy Premium Jan 7, 2022 Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom Premium Jan 7, 2022 Genomics, MDx M&A Activity Exploded in 2021 Driven by COVID-19 Testing Tailwinds Jan 6, 2022 Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.